Literature DB >> 16227776

Should white coat hypertension be treated?

Thomas G Pickering1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16227776      PMCID： PMC8109475          DOI： 10.1111/j.1524-6175.2005.04132.x

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  28 in total

1.  Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study.

Authors:  Roberto Sega; Rita Facchetti; Michele Bombelli; Giancarlo Cesana; Giovanni Corrao; Guido Grassi; Giuseppe Mancia
Journal:  Circulation       Date:  2005-04-04       Impact factor: 29.690

2.  Effects of nifedipine SR and enalapril on office, home and ambulatory blood pressure in "white-coat" systemic hypertension.

Authors:  T Ashida; H Abe; Y Kawano; K Yoshida; G Kimura; S Kojima; H Yoshimi; M Kawamura; M Imanishi; T Sanai
Journal:  Am J Cardiol       Date:  1990-08-15       Impact factor: 2.778

3.  Circulating homocysteine levels in sustained and white coat hypertension.

Authors:  S D Pierdomenico; A Bucci; D Lapenna; F M Lattanzio; L Talone; F Cuccurullo; A Mezzetti
Journal:  J Hum Hypertens       Date:  2003-03       Impact factor: 3.012

4.  Benazepril versus felodipine as supplement to bendroflumethiazide: evaluation by office and ambulatory blood pressure.

Authors: 
Journal:  Blood Press Monit       Date:  1998-04       Impact factor: 1.444

5.  Comparison of angiotensin-converting enzyme inhibitors and calcium antagonists in the treatment of mild to moderate systemic hypertension, according to baseline ambulatory blood pressure level.

Authors:  D Herpin; B Vaisse; M Pitiot; R de Gaudemaris; J M Mallion; L Poggi; J Demange
Journal:  Am J Cardiol       Date:  1992-04-01       Impact factor: 2.778

6.  Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation.

Authors:  G Mancia; A Zanchetti; E Agabiti-Rosei; G Benemio; R De Cesaris; R Fogari; A Pessina; C Porcellati; A Rappelli; A Salvetti; B Trimarco; E Agebiti-Rosei; A Pessino
Journal:  Circulation       Date:  1997-03-18       Impact factor: 29.690

7.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

Review 8.  Task Force II: blood pressure measurement and cardiovascular outcome.

Authors:  J A Staessen; R Asmar; M De Buyzere; Y Imai; G Parati; K Shimada; G Stergiou; J Redón; P Verdecchia
Journal:  Blood Press Monit       Date:  2001-12       Impact factor: 1.444

9.  When can the practicing physician suspect white coat hypertension? Statement from the Working Group on Blood Pressure Monitoring of the European Society of Hypertension.

Authors:  Paolo Verdecchia; Eoin O'Brien; Thomas Pickering; Jan A Staessen; Gianfranco Parati; Martin Myers; Paolo Palatini
Journal:  Am J Hypertens       Date:  2003-01       Impact factor: 2.689

10.  White coat hypertension is a cardiovascular risk factor: a 10-year follow-up study.

Authors:  P H Gustavsen; A Høegholm; L E Bang; K S Kristensen
Journal:  J Hum Hypertens       Date:  2003-12       Impact factor: 3.012
View more
  4 in total

Review 1.  Anxiety in the "age of hypertension".

Authors:  James Brian Byrd; Robert D Brook
Journal:  Curr Hypertens Rep       Date:  2014-10       Impact factor: 5.369

Review 2.  White coat hypertension in pediatrics.

Authors:  Alexander Jurko; Milan Minarik; Tomas Jurko; Ingrid Tonhajzerova
Journal:  Ital J Pediatr       Date:  2016-01-15       Impact factor: 2.638

3.  What is the optimal cut-off threshold in self-home blood pressure measurement?: A cohort study according to STROBE statement.

Authors:  Gabriel Coll-de-Tuero; Marc Saez; Antonio Rodriguez-Poncelas; Joan Bayó-Llibre; Marta Beltran-Vilella; Carla Reyes-Negre; Antoni Dalfó-Baqué; MªAntonia Barceló
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

4.  Comparison of pulse wave analysis between persons with white coat hypertension and normotensive persons.

Authors:  Neil J Wimmer; Kinji Sathi; Tiffany L Chen; Raymond R Townsend; Debbie L Cohen
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-07       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.